Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile

Journal of Surgical Research

Volumn 89, Issue 2, 2000, Pages 169-175

  Churchill, Matthew ^a   Chadburn, Amy ^a   Bilinski, Robyn T ^a   Bertagnolli, Monica M ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apc; Chemoprevention; Colorectal cancer; Curcumin; Mill +

Indexed keywords

CURCUMIN;

ADENOMA; ADENOMATOUS POLYP; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; FAMILIAL POLYPOSIS; HELPER CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTESTINE TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034113598     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5826     Document Type: Article

References (37)

1. Huang M.-T., Smart R. C., Wong C.-Q., Conney A. H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48:1988;5941.
2. Pereira M. A., Grubbs C. J., Barnes l. H., Li H., Olson G. R., Eto I., Juliana M., Whitaker L. M., Kelloff G. J., Steele V. E., Lubet R. A. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis. 17:1996;1305.
3. Huang M.-T., Lou Y. R., Ma W., Newmark H. L., Reuhl K. R., Conney A. H. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54:1994;5841.
4. Rao C. V., Rivenson A., Simi B., Reddy B. S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:1995;259.
5. Zhang F., Altorki N. K., Mestre J. R., Subbaramaiah K., Dannenberg A. J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 20:1999;445.
6. Liu J.-Y., Lin S.-J., Lin J.-K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis. 14:1993;857.
7. Kortula L., Kumar R. Inhibitory effect of curcumin an epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta. 122:1994;597.
8. Kortula L., Cheung J. Y., Mendelsohn J., Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis. 16:1995;1741.
9. Singh S., Aggarwal B. B. Activation of transcription factor NF-kappa B is suppressed by curcumin. J. Biol. Chem. 270:1995;24995.
10. Huang T.-S., Lee S.-C., Lin J.-K. Suppression of c-jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA. 88:1991;5292.
11. Srivastava R. Inhibition of neutrophil response by curcumin. Agents Actions. 28:1989;298.
12. Chan M. M.-Y. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 49:1995;1551.
13. Gonda R., Tomoda M., Shimizu N., Kanari M. Characterization of polysaccharides having activity on the reticuloendothelial system from the rhizome of C. longa. Chem. Pharm. Bull. 38:1990;482.
14. Yasni S., Yoshiie K., Oda H., Sugano M., Imaizumi K. Dietary Curcuma xanthorrhiza Roxb increases mitogenic responses of splenic lymphocytes in rats, and alters populations of lymphocytes in mice. J. Nutr. Sci. Vitaminol. 39:1993;345.
15. + T cells by suppressing interleukin-12 production in macrophages. Br. J. Pharmacol. 128:1999;380.
16. Huang M.-T., Lysz T., Ferraro T., Abidi T. F., Laskin J. D., Conney A. H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:1991;813.
17. Huang M.-T., Wang Z. Y., Georgiadis C. A., Laskin J. D., Conney A. H. Inhibitory effect of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 13:1992;2183.
18. Chinery R., Beauchamp R. D., Shyr Y., Kirkland S. C., Coffey R. J., Morrow J. D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 58:1998;2323.
19. Tetsuka T., Baier L. D., Morrison A. D. Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric oxide synthase expression in rat mesangial cells: Evidence for post-transcriptional regulation. J. Biol. Chem. 271:1996;11689.
20. Moser A. R., Pitot H. C., Dove W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 247:1990;322.
21. Su L.-K., Kinzler K., Vogelstein B., Preisinger A. C., Moser A. R., Luongo C., Gould K., Dove W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 256:1992;668.
22. Elson, C. O.In defense of mucosal surfaces. In Paulet al. (Eds.), Mechanisms in the Pathogenesis of Enteric Diseases. New York, Plenum, 1997. Pp. 373-385.
23. Kagnoff M. F. Current concepts in mucosal immunity. III. Ontogeny and function of γδ T cells in the intestine. Am. J. Physiol. 274:1998;G455.
24. Christ A. D., Blumberg R. S. The intestinal epithelial cell: Immunological aspects. Semin. Immunopathol. 18:1997;449.
25. Banner B. F., Savas L., Baker S., Woda B. A. Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchow's Arch. B Cell Pathol. 64:1993;213.
26. Fujihashi K., Taguchi T., Aicher W. K., McGhee J. R., Bluestone J. A., Eldridge J. H., Kiyono H. Immunoregulatory functions for murine intraepithelial lymphocytes: γδ T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while αβ TCR+ T cells provide B cell help. J. Exp. Med. 175:1992;695.
27. Lionetti P., Breese E., Braegger C. P., Murch S. H., Taylor J., MacDonald T. T. T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology. 105:1993;373.
28. MacDonald T. T., Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med. 167:1988;1341.
29. Sharma R. C. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. 25:1976;1811.
30. Toda S., Miyase T., Arichi H., Tanizawa H., Takino Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm. Bull. (Tokyo). 33:1985;1725.
31. Grisham M. B., MacDermott R. P., Deitch E. A. Oxidant defense mechanisms in the human colon. Inflammation. 14:1990;669.
32. Keshavarzian A., Zapeda D., List T., Mobarhan S. High levels of reactive oxygen metabolites in colon cancer tissue: Analysis by chemiluminescence probe. Nutr. Cancer. 17:1992;243.
33. Qureshi A, Gorey T. F., Byrne P., Kay E., Keever J. M., Hennessy T. P. J. Oxygen free radical activity in experimental colonic carcinoma. Br. J. Surg. 79:1994;S28.
34. Wolin, M. S., and Mohazzab-H. K. M.Mediation of signal transduction by oxidants. In J. G. Scandalios (Ed.), Oxidative Stress and Molecular Biology of Antioxidant Defenses. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1997. Pp. 21-48.
35. Hatman L. J., Kayden H. J. A high-performance liquid chromotographic method for determination of tocopherol in plasma and cellular elements of the blood. J. Lipid Res. 20:1979;639.
36. Meydani S. N., Wu D, Santos M. S., Hayek M. G. Antioxidants and immune response in aged persons: Overview of present evidence. Am. J. Clin. Nutr. 62:1995;1462S.
37. Coquette A., Vray B., Vanderpas J. Role of vitamin E in the protection of the resident macrophage membrane against oxidative damage. Arch. Int. Physiol. Biochim. 94:1986;529.